ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
AstraZeneca eyes three-drug inhaler opportunity after trial results
June 28, 2020AstraZeneca said that the ETHOS trial of triple-drug therapy c formerly known as PT010, helped patients suffering from chronic obstructive pulmonary disease. -
Breztri Aerosphere (PT010) approved in Japan for patients with chronic obstructive pulmonary disease
June 24, 2019Breztri Aerosphere (PT010) approved in Japan for patients with chronic obstructive pulmonary disease. -
The Lancet Respiratory Medicine publishes first Phase III trial for PT010 triple combination therapy in moderate to very severe chronic obstructive pulmonary disease
September 18, 2018AstraZeneca today announced publication of results from the KRONOS Phase III trial which evaluated the efficacy and safety of triple combination therapy PT010 (budesonide/ glycopyrronium/formoterol fumarate) versus dual combination therapies Bevespi Aeros
Pharma Sources Insight January 2025
